Depression and anxiety frequently occur together or in extension of each other. According to a previous study in depressed inpatients, a high trait anxiety level correlated with a positive response to the diazepam test (DT) and a low trait anxiety level with a negative response to the test. The aim of this study is to investigate whether positive reaction to the DT is related to a positive response to fluvoxamine and whether a negative reaction to the test is related to positive response to imipramine. The DT was performed in 130 patients diagnosed with a depressive disorder. Following the DT, the patients were randomly assigned to double-blind treatment with either imipramine or fluvoxamine. Doses of both antidepressants were adjusted to attain predefined blood levels, and the outcome was evaluated 4 weeks after attaining these blood levels. Twenty-two patients had a positive response to the DT, whereas 108 patients had a negative response. Although a positive DT is correlated with a high level of trait anxiety, no differences in depressive symptomatology and antidepressant response were found between patients with a positive and a negative DT.
Akiskal, HS ( 1998) Towards a definition of generalized anxiety disorder as an anxious temperament type. Acta Psychiatr Scand (Suppl. 393): 66-73.
2.
Allgulander, C., Sheehan, DV ( 2002) Generalized anxiety disorder: raising the expectations of treatment. Psychopharmacol Bull2: 68-78.
3.
Anderson, IM ( 2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants:a meta-analysis of efficacy and tolerability. J Affect Disord58: 19-36.
4.
Asberg, M., Montgomery, SA, Perris, C., Schalling, D., Sedvall, G. ( 1978) A comprehensive psychopathological rating scale. Acta Psychiatr Scand j(Suppl. 271): 5-27.
5.
Ballenger, JC ( 2000) Anxiety and depression: optimizing treatments. Prim Care Companion J Clin Psychiatry2: 71-79.
6.
Bauer, M., Whybrow, PC, Angst, J., Versiani, M., Möller, H-J. ( 2002) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry3: 5-43.
7.
Bruijn, JA, Moleman, P., van den Broek, WW, Mulder, PG ( 2001) Trait anxiety and the effect of a single high dose of diazepam in unipolar depression. J Psychiatr Res35: 331-337.
8.
Claghorn, JL, Earl, CQ, Walczak, DD, Stoner, KA, Wong, LF, Kanter, D., et al. (1996) Fluvoxamine maleate in the treatment of depression: a single center, double-blind, placebo controlled comparison with imipramine in outpatients. J Clin Psychopharmacol16: 113-130.
9.
de Kemp, EC, Moleman, P., Hoogduin, CA, Broekman, TG, Goedhart, A., Schaap, CP, et al. (2002) Diagnosis at the First episode to differentiate antidepressant treatment responses in patients with mood and anxiety disorders. Psychopharmacology160: 67-73.
10.
Feighner, JP, Cohn, JB, Fabre, LF, Fieve, RR, Mendels, J., Shrivastava, RK, et al. (1993) A study comparing paroxetine placebo and imipramine in depressed patients. J Affect Disord28: 71-79.
11.
Felton, TM, Kang, TB, Hjorth, S., Auerbach, SB ( 2003) Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn Schmiedebergs Arch Pharmacol367: 297-305.
12.
Goodwin, RD, Gorman, JM ( 2002) Psychopharmacologic treatment of generalized anxiety disorder and the risk of major depression. Am J Psychiatry159: 1935-1937.
13.
Hamilton, M. ( 1960) A rating scale for depression. J Neurol Neurosurg Psychiatry23: 56-61.
14.
Kendler, KS, Neale, MC, Kessler, RC, Heath, AC, Eaves, LJ ( 1992) Major depression and generalized anxiety disorder. Same genes, (partly) different environments. Arch Gen Psychiatry49: 716-722.
15.
Montgomery, SA, Jugde, R. ( 2000) Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand (Suppl. 403): 9-16.
16.
Moras, K., Barlow, D. ( 1992) Definitions of secondary depression: effects on comorbidity and outcome in anxiety disorders. Psychopharmacol Bull28: 27-33.
17.
Nuller, JL, Tochilov, VA, Shirokov, VD ( 1982) The use of a diazepam test for the study of depressive state structure and for choice of therapy. Biol Psychiatry17: 791-797.
18.
Prudic, J., Haskett, RF, Mulsant, B., Malone, KM, Pettinati, HM, Stephans, S., et al. (1996) Resistance to antidepressant medications and short-term response to electroconvulsive therapy. Am J Psychiatry153: 985-992.
19.
Sackeim, HA, Prudic, J., Devanand, DP, Decina, P., Kerr, B., Malitz, S. ( 1990) The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression . J Clin Psychopharmacol10: 96-104.
20.
Sonawalla, SB, Spillmann, MK, Kolsky, AR, Alpert, JE, Nierenberg, AA, Rosenbaum, JF, et al. (1999) Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders. J Clin Psychiatry60: 580-583.
21.
Spitzer, R., Endicot, J. ( 1978) Schedule for Affective Disorders and Schizofrenia (SADS) . New York State Psychiatric Institute, Biometric Research[location].
22.
van den Broek, WW, Birkenhäger, TK, Mulder, PG, Bruijn, JA, Moleman, P. ( 2004) A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients. Psychopharmacology175: 481-486.
23.
van Valkenburg, C., Akiskal, HS, Puzantian, V., Rosental, T. ( 1984) Anxious depressions. Clinical, family history, and naturalistic outcome: comparisions with panic and major depressive disorders. J Affect Disord6: 67-82.
24.
van Valkenburg, C., Winokur, G., Lowry, M., Behar, D., van Valkenburg, D. ( 1983) Depression occurring in chronically anxious persons. Compr Psychiatry24: 285-289.
